D.E. Shaw & Co Portfolio holdings
D. E. Shaw & Co., L.P., founded in 1988 by David E. Shaw, a former Columbia University computer science professor, is a New York City-based global investment management firm renowned for pioneering quantitative investing, managing over $70 billion in assets as of late 2024. Starting with $28 million from Paloma Partners and private investors, the firm employs sophisticated mathematical models and proprietary algorithms—initially developed by a team of scientists and programmers—to exploit market anomalies across public and private markets, including equities, fixed income, and alternatives. Headquartered above a Greenwich Village bookstore in its early days, it now boasts over 2,500 employees across offices in North America, Europe, and Asia, led by a seven-member Executive Committee since Shaw stepped back in 2001 to focus on D. E. Shaw Research. Despite setbacks like the 1998 Russia debt crisis and the 2008 financial downturn, the firm has maintained a reputation for analytical rigor, risk management, and innovation, balancing its computational roots with discretionary strategies.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Comcast
CMCSA
|
+$354M |
| 2 |
Wells Fargo
WFC
|
+$274M |
| 3 |
IBM
IBM
|
+$266M |
| 4 |
Qualcomm
QCOM
|
+$257M |
| 5 |
Mondelez International
MDLZ
|
+$224M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Gilead Sciences
GILD
|
+$356M |
| 2 |
PayPal
PYPL
|
+$290M |
| 3 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$261M |
| 4 |
NVIDIA
NVDA
|
+$248M |
| 5 |
AABA
Altaba Inc
AABA
|
+$245M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 13.61% |
| 2 | Healthcare | 10.26% |
| 3 | Consumer Discretionary | 10.07% |
| 4 | Financials | 8.17% |
| 5 | Communication Services | 7.92% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1426
CALL
BioMarin Pharmaceuticals
BMRN
$11.8B
| $4.47M | 0.01% |
48,000
| – | – |
|
1427
Bank of N.T. Butterfield & Son
NTB
$2.42B
| $4.46M | 0.01% |
121,867
+34,681
| +40% | +$1.18M |
|
|
LJPC
1428
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $4.46M | 0.01% |
128,184
+65,504
| +105% | +$2.11M |
|
1429
PUT
First Solar
FSLR
$21.7B
| $4.46M | 0.01% |
97,100
-29,000
| -23% | -$1.34M |
|
|
TSRO
1430
PUT
DELISTED
TESARO, Inc.
TSRO
| $4.45M | 0.01% |
34,500
| – | – |
|
|
CNCE
1431
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $4.45M | 0.01% |
301,836
-13,893
| -4% | -$202K |
|
1432
Simpson Manufacturing
SSD
$7.96B
| $4.44M | 0.01% |
90,486
-98,722
| -52% | -$4.4M |
|
1433
PUT
Williams-Sonoma
WSM
$27.2B
| $4.43M | 0.01% |
177,800
| – | – |
|
|
RESI
1434
DELISTED
Front Yard Residential Corporation Common Stock
RESI
| $4.43M | 0.01% |
398,562
+28,416
| +8% | +$346K |
|
1435
A10 Networks
ATEN
$2.39B
| $4.42M | 0.01% |
585,274
+93,835
| +19% | +$639K |
|
|
SRGA
1436
DELISTED
Surgalign Holdings, Inc. Common Stock
SRGA
| $4.42M | 0.01% |
32,405
-1,103
| -3% | -$167K |
|
1437
VanEck Semiconductor ETF
SMH
$64.9B
| $4.42M | 0.01% |
+94,800
| New | +$4.14M |
|
|
CVA
1438
DELISTED
Covanta Holding Corporation
CVA
| $4.42M | 0.01% |
297,497
-101,277
| -25% | -$1.43M |
|
1439
Smith & Wesson
SWBI
$665M
| $4.41M | 0.01% |
376,284
+114,603
| +44% | +$1.62M |
|
1440
Liberty Global Class C
LBTYK
$3.37B
| $4.39M | 0.01% |
134,224
-590,786
| -81% | -$19.1M |
|
1441
CALL
Zions Bancorporation
ZION
$10.2B
| $4.39M | 0.01% |
93,000
-10,000
| -10% | -$445K |
|
|
SCHW
1442
CALL
Charles Schwab
SCHW
$180B
| $4.39M | 0.01% |
100,300
| – | – |
|
|
BT
1443
DELISTED
BT Group plc (ADR)
BT
| $4.38M | 0.01% |
+227,538
| New | +$4.45M |
|
1444
Vishay Precision Group
VPG
$1.29B
| $4.38M | 0.01% |
179,322
+7,196
| +4% | +$143K |
|
1445
Kilroy Realty
KRC
$4.58B
| $4.37M | 0.01% |
+61,454
| New | +$4.32M |
|
1446
American Express
AXP
$228B
| $4.37M | 0.01% |
48,268
+14,431
| +43% | +$1.24M |
|
|
BGG
1447
DELISTED
Briggs & Stratton Corp.
BGG
| $4.36M | 0.01% |
185,532
+128,001
| +222% | +$2.91M |
|
1448
Radware
RDWR
$1.25B
| $4.36M | 0.01% |
258,426
+72,668
| +39% | +$1.26M |
|
1449
Cable One
CABO
$224M
| $4.35M | 0.01% |
6,028
-300
| -5% | -$222K |
|
|
DENN
1450
DELISTED
Denny's
DENN
| $4.35M | 0.01% |
349,630
-20,898
| -6% | -$248K |
|
Similar funds
D.E. Shaw & Co's Q3 2017 Portfolio in Review
As of Q3 2017, D.E. Shaw & Co held 3,794 positions worth $65.1B, up 7.7% from $60.5B the previous quarter. Its ten largest holdings account for 9.6% of the portfolio.
D.E. Shaw & Co's Q3 2017 filing shows 469 new, 1,367 increased, 1,237 reduced and 370 closed positions. Its largest new stake was Baker Hughes: 3,076,914 shares worth $113M. The largest sale was Gilead Sciences, an estimated $356M.
By sector, the portfolio is most concentrated in Technology at 14% of assets, down from 14% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- D.E. Shaw & Co's largest Q3 2017 buy was Baker Hughes: 3,076,914 shares worth $113M.
- D.E. Shaw & Co added most to Comcast in Q3 2017, an estimated $354M increase.
- D.E. Shaw & Co's biggest Q3 2017 reduction was Gilead Sciences, cutting an estimated $356M.
- D.E. Shaw & Co fully exited Mobileye N.V. in Q3 2017, selling an estimated $72.4M.
- D.E. Shaw & Co's ten largest holdings make up 9.6% of its $65.1B portfolio in Q3 2017.
- D.E. Shaw & Co opened 469 new positions and closed 370 in Q3 2017.
- D.E. Shaw & Co's portfolio value rose 7.7% quarter-over-quarter to $65.1B.
Based on D.E. Shaw & Co's 13F filing for Q3 2017, filed 14 Nov 2017.